Celostatin Lar 20 mg Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Celostatin Lar 20 mg Injection contains long-acting (LAR) octreotide, a somatostatin analogue. Its labelling describes it for the treatment of acromegaly, carcinoid tumours, and bleeding oesophageal varices, and for preventing complications following surgery of the pancreas. It is described as inhibiting growth hormone and lowering food-pipe bleeding by narrowing the blood vessels. It is injected only by professional doctors, who set the dosage and duration.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of acromegaly
- Described for the treatment of carcinoid tumours
- Described for the treatment of bleeding oesophageal varices
- Described for preventing complications following surgery of the pancreas
Described Dosage & Administration
- Injected only by a professional doctor; it should not be self-administered
- The dosage and duration are set by the doctor for smooth treatment
Described Side Effects
Commonly described side effects include:
- Diarrhoea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in the blood
- Injection site reaction
These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- Given only by a professional doctor, who sets the dosage and duration
- Not to be self-administered
- Blood glucose may be affected and should be monitored as advised
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains long-acting octreotide and is used for acromegaly, carcinoid tumours, and bleeding oesophageal varices, and for preventing complications after pancreatic surgery. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as injected only by a professional doctor, who sets the dosage and duration; it is not to be self-administered.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.